Compare LMAT & ETG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LMAT | ETG |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2006 | 2003 |
| Metric | LMAT | ETG |
|---|---|---|
| Price | $95.59 | $22.80 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $105.80 | N/A |
| AVG Volume (30 Days) | ★ 303.1K | 73.1K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | ★ 30.57 | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $249,602,000.00 | N/A |
| Revenue This Year | $14.21 | N/A |
| Revenue Next Year | $8.88 | N/A |
| P/E Ratio | $143.37 | ★ N/A |
| Revenue Growth | ★ 13.53 | N/A |
| 52 Week Low | $79.01 | $19.34 |
| 52 Week High | $118.01 | $23.76 |
| Indicator | LMAT | ETG |
|---|---|---|
| Relative Strength Index (RSI) | 42.33 | 43.49 |
| Support Level | $95.47 | $22.76 |
| Resistance Level | $97.83 | $23.44 |
| Average True Range (ATR) | 3.46 | 0.26 |
| MACD | -0.58 | -0.07 |
| Stochastic Oscillator | 2.30 | 11.83 |
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Eaton Vance Tax Advgd Gbl Div Inc Fd is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of aerospace and defense, capital markets, diversified telecommunication services, electrical equipment, biotechnology, banks, and other areas.